SummaryThe objective of this observational study was to compare the efficacy of levetiracetam and topiramate during the first 15 days of add-on treatment in adults with refractory partial epilepsy.Two cohorts of patients with ≥3 simple or complex partial seizures with or without secondary generalisation per month over an 8-week baseline period received levetiracetam or topiramate in two distinct phases, in addition to standard antiepileptic treatment. During the first 15 days of the therapy, levetiracetam was added at the dosage of 250mg b.i.d. or topiramate at 25mg o.i.d. Efficacy parameters included number of seizure-free days (SFDs), mean and percent reduction in seizure frequency (in general and by type), and number of seizure-free pati...
SummaryAn open, prospective, observational study was performed to assess efficacy and adverse-event ...
Rationale: Levetiracetam (LEV) is a newantiepileptic drug (AED) indicated as adjunctive therapy in t...
This prospective, open-label study evaluated the efficacy and safety of adjunctive levetiracetam (LE...
The objective of this observational study was to compare the efficacy of levetiracetam and topiramat...
SummaryThe objective of this observational study was to compare the efficacy of levetiracetam and to...
Few comparative clinical trials of newer antiepileptic drugs (AEDs) in patients with refractory part...
Purpose: To evaluate the long-term clinical usefulness of levetiracetam (LEV, Keppra(R)(1)) as add-o...
SummaryObjectiveTwo of the most commonly prescribed new antiepileptic drugs as add-on therapy for pa...
OBJECTIVE: To prospectively assess the safety and efficacy of levetiracetam in patients with uncontr...
AbstractThis prospective open-label study used flexible dosing schedules of levetiracetam (LEV) in p...
AbstractThe aim of this study was to determine the tolerability and efficacy of two oral regimens of...
SummaryThis prospective, open-label study evaluated the efficacy and safety of adjunctive levetirace...
SummaryObjectiveAim of the study was to assess the efficacy and safety of levetiracetam as add-on tr...
AbstractThis prospective observational study explored the efficacy and tolerability of levetiracetam...
AbstractBackground: The novel antiepileptic drug (AED) levetiracetam (LEV, Keppra®) is indicated as ...
SummaryAn open, prospective, observational study was performed to assess efficacy and adverse-event ...
Rationale: Levetiracetam (LEV) is a newantiepileptic drug (AED) indicated as adjunctive therapy in t...
This prospective, open-label study evaluated the efficacy and safety of adjunctive levetiracetam (LE...
The objective of this observational study was to compare the efficacy of levetiracetam and topiramat...
SummaryThe objective of this observational study was to compare the efficacy of levetiracetam and to...
Few comparative clinical trials of newer antiepileptic drugs (AEDs) in patients with refractory part...
Purpose: To evaluate the long-term clinical usefulness of levetiracetam (LEV, Keppra(R)(1)) as add-o...
SummaryObjectiveTwo of the most commonly prescribed new antiepileptic drugs as add-on therapy for pa...
OBJECTIVE: To prospectively assess the safety and efficacy of levetiracetam in patients with uncontr...
AbstractThis prospective open-label study used flexible dosing schedules of levetiracetam (LEV) in p...
AbstractThe aim of this study was to determine the tolerability and efficacy of two oral regimens of...
SummaryThis prospective, open-label study evaluated the efficacy and safety of adjunctive levetirace...
SummaryObjectiveAim of the study was to assess the efficacy and safety of levetiracetam as add-on tr...
AbstractThis prospective observational study explored the efficacy and tolerability of levetiracetam...
AbstractBackground: The novel antiepileptic drug (AED) levetiracetam (LEV, Keppra®) is indicated as ...
SummaryAn open, prospective, observational study was performed to assess efficacy and adverse-event ...
Rationale: Levetiracetam (LEV) is a newantiepileptic drug (AED) indicated as adjunctive therapy in t...
This prospective, open-label study evaluated the efficacy and safety of adjunctive levetiracetam (LE...